Remove 2019 Remove Events Remove Topical
article thumbnail

Top Canna Law Blog Posts of 2019

Canna Law Blog

2019 was another big year for cannabis, and another busy year for the Canna Law Blog. These are the Canna Law Blog’s Biggest Hits of 2019, in alphabetical order: BREAKING NEWS: FDA Issues More Guidance on CBD Products. What’s the overarching theme of our top 2019 posts? Three letters: C-B-D.

Law
article thumbnail

The Emerald Cup 2019 winners and where to buy them

Leafly

The post The Emerald Cup 2019 winners and where to buy them appeared first on Leafly. The strain Ice Cream Cake dominates. Also don’t miss Runtz, Alien Labs’ Baklava, and Zendo peanut butter.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BREAKING NEWS: FDA Issues More Guidance on CBD Products

Canna Law Blog

On April 2, 2019, the federal Food & Drug Administration (“FDA”) Commissioner Scott Gottlieb issued a press release on hemp and hemp-derived cannabidiol (“Hemp CBD”). During this time, the FDA has apparently been scrambling to figure out what to do about Hemp CBD (which you can read about here and here ).

CBD
article thumbnail

CannX cannabis conference returns in-person to Tel Aviv

The Cannigma

The sixth annual CannX is the first in-person event since 2019. We look forward to welcoming you in-person to CannX 2022 – for what is sure to be an outstanding event!” “We are very much excited to announce that CannX 2022 will be held in-person,” said Yossi Bornstein, event organizer. Related Stories.

article thumbnail

Seyfarth on CBD – February 2020 Update

The Blunt Truth

CBD continues to flourish in the markets despite lack of federal regulations, and we’ve identified some significant events that indicate there’s no sign it’s stopping. Topical CBD Pain-Relief Receives FDA Product Listing Certification. This certification is the first of its kind for a topical OTC drug containing CBD.

CBD
article thumbnail

Cannabis laws in Japan: Is weed legal?

The Cannigma

In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes. CBD has become especially trendy in Tokyo, where CBD shops and cafes allow for the on-site consumption of CBD in edibles and topical treatments. Shutterstock).

Law
article thumbnail

Cannabis Reclassification Delayed

Sensi Seeds

The topic of cannabis is currently highly politicised. The Commission on Narcotic Drugs is meeting in March 2019 to update the Single Convention. We will, of course, keep you updated with events as they happen. The WHO’s actions are feeding speculation about political motives. This could change soon.